Researchers at the ICR co-led a recent study showing that it is possible to reverse drug resistance and slow tumour progression in prostate cancer by targeting myeloid white blood cells. Tumours can ...

Jesse was two years old when he was diagnosed with B-cell acute lymphoblastic leukaemia, a type of blood and bone marrow ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

Researchers have carried out an in-depth analysis of 10,478 cancer genomes across 35 different cancer types, identifying 330 potential cancer-driving genes, 74 of which are newly associated with ...

Dr Jessica May Hislop joined The Institute of Cancer Research as a Bioinformatician in the Houlston Lab in the Genetics and Epidemiology division. Together with her colleagues, she is working towards ...

Dr Jessica May Hislop joined The Institute of Cancer Research as a Bioinformatician in the Houlston Lab in the Genetics and Epidemiology division. Together with her colleagues, she is working towards ...

Image: The Man Van. Credit: The Man Van and The Royal Marsden NHS Foundation Trust. Mobile testing ‘Man Van’ can diagnose ...

Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society. Video: ICR Chief Executive Kristian Helin gives an overview ...

The Institute of Cancer Research has outlined its position on a number of policy issues in scientific and medical research. Our statements can be read and downloaded below. You may also be interested ...

This Christmas, give the gift of research to help someone's mum, sister, nan, or friend survive cancer and look forward to spending more precious time with their loved ones. "I’m here to tell my story ...

The Chief Executive is responsible to the Board of Trustees for the overall direction of the ICR’s management, research and academic activities and the effective prosecution of its work; and for ...